Learn about the RPA and why superior speed and inhibitor tolerance mean it's replacing LAMP for field and point-of-care testing. Recorded at the 2025 Association for Molecular Pathology (AMP) conference, this workshop is an introduction to RPA and its capabilities, including multiplexing and RT-RPA.
Curtis Knox explains the advantages of RPA, including speed, inhibitor tolerance, multiplexing capability, and ability to amplify RNA with an added RT.